BHC stock rises 14.7% in a week after a report surfaced that the company is in talks with Jefferies Financial Group to push ...

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

Bausch Health Cos. is working with Jefferies Financial Group to explore refinancing some of its debt to aid a long-planned ...

Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical corporate board, ...

Bausch + Lomb (BLCO) stock will be in focus as company is exploring a sale to address concerns raised over its separation ...

Bausch + Lomb was put up for sale after a planned separation from its parent company Bausch Health, formerly known as Valeant ...

Analyst Glen Santangelo of Jefferies reiterated a Buy rating on Bausch Health Companies (BHC – Research Report), reducing the price ...

It had formerly sought to spin off from parent Bausch Health in a stock-for-stock deal. But Bausch Health's lenders would apparently prefer a sale for cash. The stock is surging today on news the ...

Bausch (BHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Bausch + Lomb Corp. shares rose the most ever following a report that the eye-care company is considering selling itself to ...

Bausch Health Cos. Bausch Health is saddled with debt of $21 billion, nearly $10 billion of which is set to mature in 2027. In July, Bausch Health pushed back against a research firm's report that ...